Alliar Medicos A Frente SA traded at 4.15 this Friday February 6th, increasing 0.01 or 0.24 percent since the previous trading session. Looking back, over the last four weeks, Alliar Medicos A Frente gained 10.17 percent. Over the last 12 months, its price fell by 59.27 percent. Looking ahead, we forecast Alliar Medicos A Frente SA to be priced at 4.57 by the end of this quarter and at 4.23 in one year, according to Trading Economics global macro models projections and analysts expectations.
Allianca Saude e Participacoes SA is a Brazil-based company which engages in the healthcare services & equipment business sector. The Company and its subsidiaries have the corporate purpose in the provision of medical services diagnosis, including: image diagnosis and graphic methods; nuclear medicine and cytology; pathological anatomy; and clinical analyses, directly or using specialized medical companies and contracted laboratories, as well as other services diagnostic support aids. The Company and its subsidiaries also operate in the exploration of activities related to: import, for own use of medical-hospital equipment, diagnostic kits and related equipment in general; consultancy, advice, courses and lectures in the health area; and scientific and technological research and development in the field of diagnostic medicine; preparation, editing, publication and distribution of newspapers, books, magazines, periodicals and other written communication vehicles.